{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:43:39Z","timestamp":1785242619304,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ30847"],"award-info":[{"award-number":["2023JJ30847"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12029-024-01067-x","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T14:02:15Z","timestamp":1716559335000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Characteristics and Outcomes of\n            Pembrolizumab Induced Gastritis: A Systematic Review of the Literature"],"prefix":"10.1007","volume":"55","author":[{"given":"Haibo","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"issue":"12","key":"1067_CR1","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/14737140.2021.1996228","volume":"21","author":"LG de Sousa","year":"2021","unstructured":"de Sousa LG, Ferrarotto R. Pembrolizumab in the first-line\n                    treatment of advanced head and neck cancer. Expert Rev Anticancer Ther.\n                    2021;21(12):1321\u201331. https:\/\/doi.org\/10.1080\/14737140.2021.1996228.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"10","key":"1067_CR2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/14712598.2018.1522300","volume":"18","author":"K Ninomiya","year":"2018","unstructured":"Ninomiya K, Hotta K. Pembrolizumab for the first-line treatment of\n                    non-small cell lung cancer. Expert Opin Biol Ther. 2018;18(10):1015\u201321. https:\/\/doi.org\/10.1080\/14712598.2018.1522300.","journal-title":"Expert Opin Biol Ther"},{"issue":"11","key":"1067_CR3","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1080\/21645515.2016.1199310","volume":"12","author":"G Kwok","year":"2016","unstructured":"Kwok G, Yau TC, Chiu JW, Tse E, Kwong YL. Pembrolizumab (Keytruda).\n                    Hum Vaccin Immunother. 2016;12(11):2777\u201389. https:\/\/doi.org\/10.1080\/21645515.2016.1199310.","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"1067_CR4","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s10620-020-06441-w","volume":"66","author":"Y Hayashi","year":"2021","unstructured":"Hayashi Y, Hosoe N, Takabayashi K, Limpias Kamiya KJL, Tsugaru K,\n                    Shimozaki K, et al. Clinical, endoscopic, and pathological characteristics of\n                    Immune Checkpoint inhibitor-Induced Gastroenterocolitis. Dig Dis Sci.\n                    2021;66(6):2129\u201334. https:\/\/doi.org\/10.1007\/s10620-020-06441-w.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"1067_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/oncolo\/oyad031","volume":"28","author":"N Farha","year":"2023","unstructured":"Farha N, Faisal MS, Allende DS, Sleiman J, Shah R, Farha N, et al.\n                    Characteristics of Immune Checkpoint inhibitor-Associated gastritis: Report from\n                    a major Tertiary Care Center. Oncologist. 2023;28(8):706\u201313. https:\/\/doi.org\/10.1093\/oncolo\/oyad031.","journal-title":"Oncologist"},{"issue":"36","key":"1067_CR6","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.21.01440","volume":"39","author":"BJ Schneider","year":"2021","unstructured":"Schneider BJ, Naidoo J, Santomasso BD, Lacchetti C, Adkins S,\n                    Anadkat M, et al. Management of Immune-related adverse events in patients\n                    treated with Immune checkpoint inhibitor therapy: ASCO Guideline Update. J Clin\n                    Oncol. 2021;39(36):4073\u2013126. https:\/\/doi.org\/10.1200\/JCO.21.01440.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1067_CR7","doi-asserted-by":"publisher","first-page":"e00334","DOI":"10.1002\/rcr2.334","volume":"6","author":"T Onuki","year":"2018","unstructured":"Onuki T, Morita E, Sakamoto N, Nagai Y, Sata M, Hagiwara K. Severe\n                    upper gastrointestinal disorders in pembrolizumab-treated non-small cell lung\n                    cancer patient. Respirol Case Rep. 2018;6(6):e00334. https:\/\/doi.org\/10.1002\/rcr2.334.","journal-title":"Respirol Case Rep"},{"issue":"3","key":"1067_CR8","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.4049\/jimmunol.181.3.1908","volume":"181","author":"GH Stummvoll","year":"2008","unstructured":"Stummvoll GH, DiPaolo RJ, Huter EN, Davidson TS, Glass D, Ward JM,\n                    Shevach EM. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis\n                    differs in pathological pattern and in susceptibility to suppression by\n                    regulatory T cells. J Immunol. 2008;181(3):1908\u201316. https:\/\/doi.org\/10.4049\/jimmunol.181.3.1908.","journal-title":"J Immunol"},{"issue":"5","key":"1067_CR9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.intimp.2009.01.022","volume":"9","author":"EN Huter","year":"2009","unstructured":"Huter EN, Stummvoll GH, DiPaolo RJ, Glass DD, Shevach EM.\n                    Pre-differentiated Th1 and Th17 effector T cells in autoimmune gastritis:\n                    Ag-specific regulatory T cells are more potent suppressors than polyclonal\n                    regulatory T cells. Int Immunopharmacol. 2009;9(5):540\u20135. https:\/\/doi.org\/10.1016\/j.intimp.2009.01.022.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"1067_CR10","doi-asserted-by":"publisher","first-page":"100419","DOI":"10.1016\/j.xcrm.2021.100419","volume":"2","author":"S Ferrian","year":"2021","unstructured":"Ferrian S, Liu CC, McCaffrey EF, Kumar R, Nowicki TS, Dawson DW, et\n                    al. Multiplexed imaging reveals an IFN-\u03b3-driven inflammatory state in\n                    nivolumab-associated gastritis. Cell Rep Med. 2021;2(10):100419. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100419.","journal-title":"Cell Rep Med"},{"issue":"18","key":"1067_CR11","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.3748\/wjg.v20.i18.5461","volume":"20","author":"J Watari","year":"2014","unstructured":"Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, et al.\n                    Helicobacter pylori associated chronic gastritis, clinical syndromes,\n                    precancerous lesions, and pathogenesis of gastric cancer development. World J\n                    Gastroenterol. 2014;20(18):5461\u201373. https:\/\/doi.org\/10.3748\/wjg.v20.i18.5461.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1067_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.path.2017.07.003","volume":"10","author":"WT Choi","year":"2017","unstructured":"Choi WT, Lauwers GY. Patterns of gastric Injury: Beyond\n                    Helicobacter Pylori. Surg Pathol Clin. 2017;10(4):801\u201322. https:\/\/doi.org\/10.1016\/j.path.2017.07.003.","journal-title":"Surg Pathol Clin"},{"issue":"6","key":"1067_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.dld.2020.12.002","volume":"53","author":"PJ Yeh","year":"2021","unstructured":"Yeh PJ, Chiu CT, Lai MW, Wu RC, Kuo CJ, Hsu JT, et al.\n                    Cytomegalovirus gastritis: clinicopathological profile. Dig Liver Dis.\n                    2021;53(6):722\u20138. https:\/\/doi.org\/10.1016\/j.dld.2020.12.002.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"1067_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.32074\/1591-951X-163","volume":"112","author":"G Pennelli","year":"2020","unstructured":"Pennelli G, Grillo F, Galuppini F, Ingravallo G, Pilozzi E, Rugge\n                    M, et al. Gastritis: update on etiological features and histological practical\n                    approach. Pathologica. 2020;112(3):153\u201365. https:\/\/doi.org\/10.32074\/1591-951X-163.","journal-title":"Pathologica"},{"issue":"4","key":"1067_CR15","doi-asserted-by":"publisher","first-page":"ofad164","DOI":"10.1093\/ofid\/ofad164","volume":"10","author":"A Anastasopoulou","year":"2023","unstructured":"Anastasopoulou A, Samarkos M, Diamantopoulos P, Vourlakou C, Ziogas\n                    DC, Avramopoulos P, et al. Cytomegalovirus infections in patients treated with\n                    Immune Checkpoint inhibitors for solid malignancies. Open Forum Infect Dis.\n                    2023;10(4):ofad164. https:\/\/doi.org\/10.1093\/ofid\/ofad164.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"1067_CR16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.17235\/reed.2022.9158\/2022","volume":"115","author":"SR Vallejo Rivera","year":"2023","unstructured":"Vallejo Rivera SR, Nicol\u00e1s Niza L, Bonilla L\u00f3pez L, D\u00edaz Concepci\u00f3n\n                    J. Severe gastritis in a patient treated with immunotherapy: immune-mediated or\n                    reactivation of cytomegalovirus? Rev Esp Enferm Dig. 2023;115(10):578\u20139. https:\/\/doi.org\/10.17235\/reed.2022.9158\/2022.","journal-title":"Rev Esp Enferm Dig"},{"issue":"5","key":"1067_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.14740\/gr1068w","volume":"11","author":"J Lu","year":"2018","unstructured":"Lu J, Firpi-Morell RJ, Dang LH, Lai J, Liu X. An unusual case of\n                    Gastritis in one patient receiving PD-1 blocking therapy: coexisting\n                    Immune-related gastritis and cytomegaloviral infection. Gastroenterol Res.\n                    2018;11(5):383\u20137. https:\/\/doi.org\/10.14740\/gr1068w.","journal-title":"Gastroenterol Res"},{"issue":"18","key":"1067_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ijms21186652","volume":"21","author":"G Steinbuss","year":"2020","unstructured":"Steinbuss G, Kriegsmann K, Kriegsmann M. Identification of\n                    Gastritis subtypes by Convolutional Neuronal Networks on Histological Images of\n                    Antrum and Corpus Biopsies. Int J Mol Sci. 2020;21(18):11. https:\/\/doi.org\/10.3390\/ijms21186652.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1067_CR19","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1055\/a-2000-5705.36963423","volume":"61","author":"ME Ecker","year":"2023","unstructured":"Ecker ME, Weckauf H, Tebbe S, Schuppert F. Immune-mediated\n                    gastritis in a patient with metastatic Lung Cancer due to therapy with the\n                    immune checkpoint inhibitor pembrolizumab - differences and Similarities in\n                    Comparison to endogenous autoimmune type a gastritis and a review of literature.\n                    Z Gastroenterol. 2023;61(10):1385\u201393. https:\/\/doi.org\/10.1055\/a-2000-5705.36963423.","journal-title":"Z Gastroenterol"},{"issue":"4","key":"1067_CR20","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1053\/j.gastro.2020.08.063","volume":"160","author":"M Dougan","year":"2021","unstructured":"Dougan M, Wang Y, Rubio-Tapia A, Lim JK. AGA clinical practice\n                    update on diagnosis and management of Immune checkpoint inhibitor colitis and\n                    Hepatitis. Expert Rev Gastroenterol. 2021;160(4):1384\u201393. https:\/\/doi.org\/10.1053\/j.gastro.2020.08.063.","journal-title":"Expert Rev Gastroenterol"},{"issue":"4","key":"1067_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.6004\/jnccn.2022.0020","volume":"20","author":"JA Thompson","year":"2022","unstructured":"Thompson JA, Schneider BJ, Brahmer J, Achufusi A, Armand P,\n                    Berkenstock MK, et al. Management of immunotherapy-related toxicities, Version\n                    1.2022, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw.\n                    2022;20(4):387\u2013405. https:\/\/doi.org\/10.6004\/jnccn.2022.0020.\\.","journal-title":"J Natl Compr Canc Netw"},{"issue":"10S","key":"1067_CR22","doi-asserted-by":"publisher","first-page":"e2300","DOI":"10.14309\/01.ajg.0000871304.75140.12","volume":"117","author":"AS Rivera","year":"2020","unstructured":"Rivera AS, Harne PS. Carlos Cardenas,Asif Zamir. Severe hemorrhagic\n                    gastritis in a patient receiving PD-1 inhibitor treated with high dose Proton\n                    Pump inhibitor. Am J Gastroenterol. 2020;117(10S):e2300. https:\/\/doi.org\/10.14309\/01.ajg.0000871304.75140.12.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1067_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/iju5.12568","volume":"6","author":"Y Fukiishi","year":"2022","unstructured":"Fukiishi Y, Fukuhara H, Kurano Y, Shugimoto H, Yamashita E,\n                    Karasima T, et al. A case of acute lymphocytic gastritis related to treatment\n                    with pembrolizumab for metastatic urothelial carcinoma. IJU Case Rep.\n                    2022;6(2):128\u201332. https:\/\/doi.org\/10.1002\/iju5.12568.","journal-title":"IJU Case Rep"},{"key":"1067_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7812\/TPP\/17-004","volume":"21","author":"D Atwal","year":"2017","unstructured":"Atwal D, Joshi KP, Ravilla R, Mahmoud F. Pembrolizumab-Induced\n                    Pancytopenia: a Case Report. Perm J. 2017;21:17\u2013004. https:\/\/doi.org\/10.7812\/TPP\/17-004.","journal-title":"Perm J"},{"issue":"9","key":"1067_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/jclinpath-2020-206540","volume":"73","author":"L Rovedatti","year":"2020","unstructured":"Rovedatti L, Lenti MV, Vanoli A, Feltri M, De Grazia F, Di Sabatino\n                    A. Nivolumab-associated active neutrophilic gastritis. J Clin Pathol.\n                    2020;73(9):605\u20136. https:\/\/doi.org\/10.1136\/jclinpath-2020-206540.","journal-title":"J Clin Pathol"},{"issue":"18","key":"1067_CR26","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.12998\/wjcc.v11.i18.4350","volume":"11","author":"E Cijauskaite","year":"2023","unstructured":"Cijauskaite E, Kazenaite E, Strainiene S, Sadauskaite G, Kurlinkus\n                    B. Nivolumab-induced tumour-like gastritis: a case report. World J Clin Cases.\n                    2023;11(18):4350\u20139. https:\/\/doi.org\/10.12998\/wjcc.v11.i18.4350.","journal-title":"World J Clin Cases"},{"key":"1067_CR27","doi-asserted-by":"publisher","first-page":"725549","DOI":"10.3389\/fonc.2021.725549","volume":"11","author":"JM Placke","year":"2021","unstructured":"Placke JM, Rawitzer J, Reis H, Rashidi-Alavijeh J, Livingstone E,\n                    Ugurel S, et al. Apoptotic gastritis in Melanoma patients treated with\n                    PD-1-Based Immune Checkpoint Inhibition - Clinical and histopathological\n                    findings including the diagnostic value of anti-caspase-3 immunohistochemistry.\n                    Front Oncol. 2021;11:725549. https:\/\/doi.org\/10.3389\/fonc.2021.725549.","journal-title":"Front Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-024-01067-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-024-01067-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-024-01067-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T11:14:04Z","timestamp":1724670844000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-024-01067-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1007\/s12029-024-01067-x","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"5 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require an ethical board approval because the\n                    study was a retrospective study and did not involve sensitive personal\n                    information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}